VALDOXAN Trademark

Trademark Overview

On Wednesday, March 20, 2019, a trademark application was filed for VALDOXAN with the United States Patent and Trademark Office. The USPTO has given the VALDOXAN trademark a serial number of 88348638. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 10, 2022. This trademark is owned by BIOFARMA. The VALDOXAN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for use in the treatment of diseases of the central nervous system
valdoxan

General Information

Serial Number88348638
Word MarkVALDOXAN
Filing DateWednesday, March 20, 2019
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 10, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 9, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for use in the treatment of diseases of the central nervous system
Translation of Words in MarkThe wording "VALDOXAN" has no meaning in a foreign language.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, April 8, 2019
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBIOFARMA
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuresnes Cedex 92284
FR
Party NameBIOFARMA
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuresnes Cedex 92284
FR

Trademark Events

Event DateEvent Description
Tuesday, October 11, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, October 10, 2022ABANDONMENT - NO USE STATEMENT FILED
Tuesday, February 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 7, 2022SOU EXTENSION 5 GRANTED
Monday, January 31, 2022SOU EXTENSION 5 FILED
Monday, February 7, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, January 31, 2022TEAS EXTENSION RECEIVED
Tuesday, August 31, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 27, 2021SOU EXTENSION 4 GRANTED
Friday, August 27, 2021SOU EXTENSION 4 FILED
Friday, August 27, 2021TEAS EXTENSION RECEIVED
Saturday, February 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 11, 2021SOU EXTENSION 3 GRANTED
Thursday, February 11, 2021SOU EXTENSION 3 FILED
Thursday, February 11, 2021TEAS EXTENSION RECEIVED
Thursday, August 27, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, August 25, 2020SOU EXTENSION 2 GRANTED
Tuesday, August 25, 2020SOU EXTENSION 2 FILED
Tuesday, August 25, 2020TEAS EXTENSION RECEIVED
Saturday, January 11, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, January 9, 2020SOU EXTENSION 1 GRANTED
Thursday, January 9, 2020SOU EXTENSION 1 FILED
Thursday, January 9, 2020TEAS EXTENSION RECEIVED
Tuesday, September 3, 2019NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 9, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 9, 2019PUBLISHED FOR OPPOSITION
Wednesday, June 19, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, May 31, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 31, 2019ASSIGNED TO EXAMINER
Monday, April 8, 2019NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, March 23, 2019NEW APPLICATION ENTERED IN TRAM

Related Keywords

valdoxan nervous system central diseases preparations treatment pharmaceutical